Clinical and paraclinical data of the efficacy of metabolic group drugs using in the complex treatment of the patients with long-term consequences after mild closed traumatic brain injury.

MD, PhD Y. Lekomtseva

State Institute of Neurology, Psychiatry and Narcology of the National Academy of Medical Sciences of Ukraine, Department of Neurology, Department of Functional Neurosurgery and Paroxysmal States

To evaluate the clinical and paraclinical data of the efficacy of metabolic group drugs using in the complex treatment of the patients with long-term consequences after closed mild traumatic brain injury.

Materials and methods: Forty-two patients with long-term consequences after closed mild traumatic brain injury (1 group) were investigated with mean age 35,66±11,08 years, 18 women and 24 men whom additionally were added the following complex: ethylmethylhydroxypyridine succinate 100 mg intramuscular every day (28 days) together with cholin alfosceras 250 mg intramuscular every day (14 days). Control group — 39 patients with long-term consequences after mild brain traumatic injury (2 group) who didn’t receive the proposed complex with the mean age of 30,29±9,24 years; 16 women and 23 men. Clinical and neurological investigations were performed, vegetative functional state was evaluated by standard tests.

Results: It was noted the positive influence of metabolic group drugs in treatment of the severity of vegetative disturbances: before treatment according to vegetative scale data in 1 gr. was 42±2,3 points, after treatment — 21,8±1,9; 2 gr. accordingly, 45±4,6 and 33,8±3,1 (p<0,05). During investigation of vegetative tonus in 35 patients (83.33%) from 1 gr. Statistically (p<0,05) decreasing of the sympathic tonus in parameters was found which were higher before treatment.

During investigation of vegetative reactivity it was registered the statistical (p<0,05) normalization of vegetative reactivity data in patients from 1 gr. Positive dynamics of cephalgia syndrome was noted in 70% patients from 1 gr. (r=0.03; р<0,05) compare to the patients from 2 gr. Using of metabolic drugs showed the increasing of cases of positive dynamics in psychiatric changes on 80% (р<0,05) manifesting in stable mood improvement, decreasing of irritation and anxiety, increasing of mental capacity, memorization improvement. It was found the intensive of clinical improvement in sleep quality in 83% patients from the main group which is on 70% higher compare to the patients from the comparison group (p<0,05).

Conclusion: Metabolic profile drugs in the patients with longterm consequences after traumatic brain injury showed high clinical efficacy in correction of vegetative dystonia syndrome, dyssomnia and cephalgia syndromes.

Key Words: long-term consequences after mild closed brain traumatic injury, metabolic group drugs.

https://dx.doi.org/10.15407/internalmed2020.01.064

Download.PDF(rus)

For citing:

1. Лекомцева Е.В. Клинико-параклинические показатели эффективности применения препаратов метаболической группы в комплексной терапии больных с отдаленными последствиями закрытой черепно-мозговой травмы // Східноєвропейський журнал внутрішньої та сімейної медицини. – 2020. – № 1. – С. 64-68. doi: 10.15407/internalmed2020.01.064

2. Lekomtseva Y. [Clinical and paraclinical data of the efficacy of metabolic group drugs using in the complex treatment of the patients with long-term consequences after mild closed traumatic brain injury]. Shidnoevr. z. vnutr. simejnoi med. 2020;1:64-68. doi: 10.15407/internalmed2020.01.064. Russian.

References:

1. Alieva HK. Kliniko-fiziologicheskie i biohimicheskie aspekty patologii vegetativnyh paroksizmov [dissertation]. Moscow; 1989. 212 p.

2. Bashmakov M.Ju. Panicheskie ataki (kliniko-psihofiziologicheskoe issledovanie) [dissertation]. Moscow; 1995. 132 p.

3. Belenichev IF, Buhtijarova NV, Sereda DA. Sovremennye napravlenija nejroprotekcii v terapii ostrogo perioda patologi golovnogo mozga razlichnogo geneza. Mizhnarodnyi nevrolohichnyi zhurnal. 2010;2 (32):76-88. Russian.

4. Vegetativnye rasstrojstva: klinika, diagnostika, lechenie. Vejna AM, editor. Moscow: Medicinskoe informacionnoe agentstvo;2000. 752 р. Russian.

5. Korostii VI, Polishchuk VT, Zavorotnyi VI. Psykhofarmakoterapiia v kompleksnomu likuvanni ta reabilitatsii posttravmatychnoho stresovoho rozladu. Mizhnarodnyi nevrolohichnyi zhurnal. 2015; 6(76):59-71. Russian.

6. Saakjan VM, Patrikjan DA, Fanardzhjan RV, Minasjan AA. Opyt primenenija aktovegina v kompleksnom lechenii ushibov golovnogo mozga srednej i tjazheloj stepeni. Mizhnarodnyi nevrolohichnyi zhurnal. 2010;7(37):85-87. Russian.

7. Nevrologija. Samujel’s М, editor. Perevod s angl. Moscow: Praktika;1997. 638 р. Russian.

8. Li MJ, Liu LY, Chen L, Cai J,Wan Y, Xing GG. Chronic stress exacerbates neuropathic pain via the integration of stress-affect-related information with nociceptive information in the central nucleus of the amygdala. PAIN. 2017;158(4):717-739. http://dx.doi.org/10.1097/j.pain.0000000000000827
https://doi.org/10.1097/j.pain.0000000000000827

9. Perkin GD. Neurology in general practice. The United Kingdom: Dunitz Ltd; 2002. 90 p. https://doi.org/10.3109/9780203215333
https://doi.org/10.3109/9780203215333